Brattea

Shanghai, China · Founded 2013 · Privately Held (backing)

Developer of hypertension interventional devices designed for medical health. Brattea is based in Shanghai, China and was founded in 2013. Its last reported valuation was $422 million in Feb 2025. It has raised $144 million.

Last reported valuation
$422.3M
Oct 2026
Priced at
—
Total raised
$144.3M
Last round
—

Who backs Brattea?

20 investors
InvestorType
SAIC Capital ChinaVenture capital
Northern Light Venture CapitalOther
Dalton VentureVenture capital
CCB InternationalPE / buyout
Shanghai Healthcare CapitalPE / buyout
SpinnotecOther
Marathon Venture PartnersVenture capital
Xinyi Asset ManagementOther
BioTrack Capital—
Bison Capital Financial Holdings—
+ 10 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Brattea investors

20 investors are on record for Brattea, including SAIC Capital China, Northern Light Venture Capital, Dalton Venture and CCB International. By type, the record holds 3 venture capital firms and 2 private equity firms.

Free account
More of Brattea with a free account
  • ·The complete investor list: 20 names
  • ·Watch Brattea: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 20 firms already write checks for companies like Brattea. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View